Skip to main content

Mifoxin

Mifoxin
.w..
Mifoxin Tablets 250 & 500 mg (film Coated Tablets) 
Bread Spectrum Antibiotic 
Composition: 
Each tablet contains 
Ciproflcxacin (as HCI monohydrata) 250 & 500 mg. 
Properties: 
Mifosin ( ciproflosacin) is a potent antibacterial agent of flouroquinolones,agroup of synthetic anlibacterials related to nalidixic acid but has greater systemic antibacterialactivity and having a broader spectrum. 
Mifosin is active against gram -vs bacilli sod cocci including pseudomonas, kiabsiella serratia, E. coil, shigella, sslmonetla entsrobactsr, neisseria, campylobscter, nstnrotoxigenic E. coli, haemophilua influsszas, hanmophilus parainfluenres, proteus mirabilis, proteus vulgaris, staphlococcus aureus including pencillinass producing and non producing strains and msthicitlin resistant strains) . It is moderately active against most strains of strnptococci including s. fuecalis, mycobacterium tuberculosis and clamydia trachometis. It is less active against most anaerobic bacteria. 
Mechanism of action: 
Mifosin is bactericidal and acts by inhibiting the A subunit of DNA gyrasa, a type 11 topoisomerase essential for ATP depending coiling and supercoiling of bacterial DNA. 
Absorption: 
Mifosin is well absorbed from gastrointestinal tract after oral administration , it has bioavailsbility of approximately 70%. 
Dtal 
It is distributed throughout,all body tissues and fluids. Tissue concentration ascends that of serum concentration specially in the kidneys , liver, gait bladder, lungs, gynaecological tissue and proslatic tissues, It is also distributed to saliva, nasal secretions, aqueous humor, sputum skin blister fluid, lymph, peritoneel fluid, bile, prostatic secretions and broast milk, It is also distributed through skin, fat, muscles, bones and cartilage as well as cnrnbrospinal fluid. It can crossestha placenta. 
Biotranaformatlon: 
Mainly hepetic through 4 metaboliles which account for approximately 15% of an oral dose, found in urine metebolites and are active but activity is less than the unchanged ciproflosacin which is about 
50% 
Elimination: 
- renal : approximately 50% is excreted unchanged in urine glomaruler filtration and active tubular secretion, excretion is virtually complete within 24 hours. 
- Bilisry & faecal : small amounts are excreted in bile and about 20% ix excreted in faeces within 5 days. 
- Dialysis : haumodialysix or peritoneal dialysis removes only avery smell amount, less than 10% Half life: -. 
Normal renal function is about 4 houm, with impaired renal functions it is slightly prolonged for about flto 8 hours. 
Serum, btla and urine concentrations: 
Time to peak serum concentration in fasting is about 1 to 2 hours, normally with food intake it ix about 2 hours, mean peak serum concentration afar an oral dose of 250 rag is 1.2 to 1.42 mcg)ml, after 500 mg ix 2.4 to 2.flmcglml and after 750 rag is 3.4 to 4.3 mcglml during the first 2 hours after the administration of a 250 rag dose. 
Indications & Usage: 
- respiratory tract infections : pneumoniae due to kiebsiella, haamophilus, proteus, B-coli, enterobacter, 
pseudomonas, pneumococci and staphylococci. 
Acute end chronic bronchitis and bronchopneumonis. 
- skin and soft tissue infection. - Genital infections including proxtatitis and cerercitis. 
- Bone infactiona. - E.N.T. infection. 
- Gastrointestinal infections including that of the biliary tract, diarrhea sad ealmonellosis. 
- Supticemia. - Peritonitis. 
- Pre and post operative as a prophylactic. 
Contra-Indications: 
- patients known to be hypersensitive to quinolones and nalidixic acid.. 
- Not to be administered to subjects under the age of 18 year. 
- Pregnancy and breast faeing. 
- Nnpatic function impairment, renal impairment and C.N.S. disorders. 
Side Effects: 
A few isolated cases reporting C.N.S. stimulation, crystalluria, hypersensitivity reactions in the form of skin rash, itching or swelling of face and neck have occurred. Photosensitivity and visual disturbances may occur during treatment. Patients may exhibit some dizziness, headache, diarrhea, nausea, vomiting and an unpleasant lasts. Sleep troubles am rare and do not necessitate the discontinuation of treatment but should be attended by a physician. 
Drug Interactions: 
- urinary alkalizers may increase the incidence of cryatalluria. 
- Aluminium and magnesium anti—acids as well as sucralfete may interfere with the absorption of 
ciprofloxacin. 
- Ciprofioxacin causes a delay in the hapatic metabolism of theophyllina and caffeine. 
- Probnncid decreanex the tubular secretion of ciprofloxacin. 
Dosage and Administration: 
Doses are administered on an empty stomach and tablets are swallowed together with a glass of 
water. 
- Bone, respiratory tract and skin infections : 500-750 rag b.i.d.for 14 days. 
- G.l.T. infections :500mg bi.d.fcr 5-7 days. 
- Urogenital infections : 250-500 mg b.i.d.for 1-14 days. 
- Gonococcal infections: 250-500 mg ax a single dose. 
- Other systemic infections :250-500mg b.i.d.for 10 days. 
- Usual adult prescribing limit dose is 1.5gm daily. 
Adequate fluid intake should be considered during the course of treatment. 
In renal failure or in impaired renal function , dosage intervals should be adjusted according to the 
following: 
Crestinine C.ml/min Dose 
50 ml! mm Adult dose 
30 - 50 ml I mm 250-500 mgb.id. 
5-29 ml! rain 250-500mg every 18 hours 
Flsemodialysis 250-500 mg every 24 hours 
Packing: 
- Boxes of 10 tablets of each of Mifoain 250 & 500 mg. 
(lledicament is a product which affects your health, and flu cuesumptien contrary is ixsimctons is dangemuu’?j 
- Fofum sticily em dance’s pmssipaan, the method dose sod the instoctono ultra phamraciai wtro sales the medbe,roaot Il-The doctor and the pharmacist am enpertu is medicine. fl’s benefits and risks. 
jJ-Du salty puursef iniermpt the period of h’eulmenl prescribed for you. 
- Do sot repeat the same prescriptes wichnul consutixg poor doctor. 
medirameni out of children reach Councli of Arab Health Miointem and Usion of Arsti Phanoaxixtu
MISR CO. FOR PHARM. IND S.A.E.


Comments

Popular posts from this blog

SPASMO - DIGESTIN

SPASMO   -   DIGESTIN   Digestant, Choleretic,   Enteric Coated Tablets Spasmolytic and   Antiflatulent   —   Composition:   Each tablet contains   Papain 100mg — -.“ -. Sanzyme 3500 .36 mg   Sodium delrydrochotate 10mg   Dicyclomine hydrochloride 5mg   Simethicorre 30 mg   Properties:   Spasmo - dlgsstin is a well balanced combination with specific digestivecholeretic.   spasmolytic and antillatulent properties. Spasmo - digestin provides the body with   papain, the proteolytic enzyme, in addition to sanzyme 3500 which is a rnuttienzyme   complex containing mainly protease, amyfase. tipase and cellulase.These enzymes act   upon food contents of the GIT and catalyze their conversion into simpler and easily   digestible and absorbable components. Spasmo - digestin therefore brings to   completion hydrolysis of protems into peptones and small peptides; &tarch into dextrins   ...

FLUMOX

FLUMOX Composition: Each dosage unit contains Amonycillirr (as trihydrate) Capsule 250mg 125mg   125mg Flaclosacillin (as monofrydrate)   Amonycillin (as sodium salt)   Flucloxacillin (as Sodium salt) 500mg 250mg   250mg 5mI Susp. 250mg   125mg   125mg Vll5 500mg 250mg   250mg ig   500mg   500mg Properties:   FLUMOX®   isa combination of two bactericidal penicillins: amoxycilin (broadspectwm penicillin) and flucloxacillin (penicillinase-resistant penicillin), to produce a wider spectrum of ac5vity. Flucloxacillin exerts a bactericidal action on penicillinase -producing microorganism including most staphylococci.This combination exhibits bactericidal activity against a wide range of Gram-positive and Gram-negative microorganisms including   penicillinase and 41 on peniciiinase   -   producing Staphylococci, Streptococcus pyogenes, pneumoniae, and faecalis, Corynebacterillm diphtheria...

Epimag

Epimag For The Medical Profession Only EPIMAG® Effervescent Powder Composition: Each 5 gm sachet contains: Magnesium citrate 2.125 g Properties: Magnesium ions inhibit formation of calcium oxalate crystals by combination with exogenous dietatric oxalate thus preventing formation of renal crystalluria. The citrate ions render urine alkaline so that urates may dissolve and are easily eliminated. Also, citrate ions, by chelating calcium ions, inhibit formation of calcium oxalate. Therefore, magnesium citrate may be prescribed to prevent recurrence of calcium oxalate kidney stones. Magnesium citrate is an osmotic laxative. Pharmacokinetics: Oral magnesium salts, including citrate, are generally very slowly absorbed from the gastrointestinal tract. They are excreted rapidly in the urine (absorbed fraction) and the faeces (unabsorbed fraction). Indications: • Cases of oxaluria. • Mild laxative to relieve constipation. Dosage and Administration: The contents of o...